Giovanni Brandi

9PUBLICATIONS
53CO-AUTHORS
Molecular targetsConstruction materialsCancer diagnosisChemotherapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 29, 2024
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Masuko Katoh, Yohann Loriot, Giovanni Brandi

|Aug 11, 2023
Pleural mesothelioma risk in the construction industry: a case-control study in Italy, 2000-2018.

Simona Stella, Dario Consonni, Enrica Migliore

|Jun 27, 2022
Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link.

Giovanni Brandi, Kurt Straif, Daniele Mandrioli

|Mar 16, 2022
FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary Center.

Alessandro Rizzo, Giovanni Brandi

|Nov 19, 2020
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.

Giovanni Brandi, Alessandro Rizzo, Marzia Deserti

|Jul 28, 2020
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation.

Matteo Ravaioli, Giovanni Brandi, Antonio Siniscalchi

Pageof 2